Valperinol (INN; GA 30-905) is a drug which acts as a calcium channel blocker.[1][2] It was patented as a possible sedative, antiepileptic, and/or antiparkinsonian agent, but was never marketed.[3]
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C16H27NO4 |
Molar mass | 297.395 g·mol−1 |
3D model (JSmol) | |
| |
|
References
edit- ^ Thies PW, Asai A, Bán I, David S, Finner E (1984). "[The synthesis of valperinol and various 3-aminomethyl derivatives of 2,9-dioxatricyclo[4,3,1,0(3,7)]decane from didrovaltrate]". Arzneimittel-Forschung (in German). 34 (11): 1460–3. PMID 6543120.
- ^ Dose M (1984). "[Calcium antagonist properties of valperinol]". Arzneimittel-Forschung (in German). 34 (11): 1464–6. PMID 6098282.
- ^ Dictionary of Pharmacological Agents Volume 2. CRC Press. 1996-11-21. p. 2104. ISBN 978-0-412-46630-4. Retrieved 22 April 2012.